Trial
NCT01216436
Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
—
Condition
Metastatic Melanoma
Intervention
Vaccination with RNA-transfected mature autologous DC
Why stopped
The PI retired
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-25